Incidence of Phlebitis Following the Use of Peripheral IV Line at X Hospital

Sijabat, Margareta; Nduru, Sisilia Desiana; B, Ayu Monaretha; Sitanggang, Yenni Ferawati; Hutasoit, Elissa Oktoviani

doi:10.20956/icon.v5i2.10859

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this present study, 62.3 % of phlebitis has occurred in males and 37.7 % in females but no significant association was found between gender and phlebitis. The findings of the present study were in accordance with the study finding of Jacinto et al (2014) 5 which showed no association between gender and phlebitis, these findings are also in line with the findings of Tefera et al (2020) 1 which showed no association between gender and phlebitis but the findings of the present study were in contrast with the study findings of Sijabat M et al ( 2021) 12 which showed that male gender is a risk factor for phlebitis and the study done by Luyu et al(2020) 15 in which author found an association between gender and phlebitis.…”

Section: Discussionsupporting

confidence: 90%

Trailblazing exploration: Unraveling phlebitis and its enigmas in children

Sharma,

Cecilia,

Venkatesan

et al. 2023

IJPNS

View full text Add to dashboard Cite

The present study was aimed to assess the incidence of phlebitis and identify the factors that cause phlebitis in children with a peripheral intravenous cannula.A prospective observational study was conducted between 15 July 2022 to 30 November 2022 in pediatrics wards of a tertiary care hospital. 225 children with PIVC were included in the study. PIVC was observed till phlebitis developed or maximum for seven consecutive days after enrollment. Phlebitis was defined by using the Jackson VIP scale. The incidence of phlebitis was 54.22% at 95% confidence interval. There was a significant association between phlebitis and the use of crystalloids, frequency of PIVC handling per day, use of cancer drugs, and use of a three-way, method of drug administration. The mean life span of PIVC was 69.86 ±32.88 hours, and the range was 19-180 hours.The incidence of phlebitis is much higher than the acceptable limit as per Infusion Therapy Standards of Practice which should be reduced. Crystalloids, the Method of drug administration, and cancer drugs are the risk factor for phlebitis. The study suggests that most likely phlebitis occurs after three days.

show abstract

Section: Discussionsupporting

confidence: 90%

Trailblazing exploration: Unraveling phlebitis and its enigmas in children

Sharma,

Cecilia,

Venkatesan

et al. 2023

IJPNS

View full text Add to dashboard Cite

show abstract

“…As many as 84% of respondents who received continuous insulin therapy felt pain at the infusion site (Taleb et al, 2018). Incorrect location of the infusion order can also cause pain, a phlebitis symptom (Sijabat et al, 2021). In this study, respondents did not feel pain because of the relatively short order time, normal saline infusion fluids, small intravenous catheters, and the selection of the correct location.…”

Section: Discussionmentioning

confidence: 60%

A preliminary study of ecosmart intra venous system on patients’ comfort

Astarini,

Manungkalit,

Agustine

et al. 2024

JHNS

View full text Add to dashboard Cite

Intravenous fluid therapy may cause discomfort to patients most of the time. More research and innovation are needed to develop infusion devices to provide a more comfortable feeling for patients receiving the therapy. This preliminary study analyzed the effect of economical and smart (ecosmart) infusion systems on comfort in healthy adults. The one-group post-test-only design was used in this pre-experimental investigation. A range of ages, gender, body weight, body temperature, and normal blood pressure selected participants. An independently created, valid, and reliable tool was used to measure comfort. Data analysis employed a t-test on a single sample. Fifteen nursing students are participating as sampling objects. The average comfort score for the study's participants was 11.2 (SD = 2.5967; p < 0.05). The result indicates that the participants are at ease using the ecosmart system. The respondents' sense of comfort related to the instrument showed comfort or relaxation. Keywords: Nursing care; ecosmart; comfort; patient-centered care; hospital; fluid therapy

show abstract

“…The evidence revealed that when drugs or blood is administer, the vein become in ltrated faster due to the irritation effect of drug and clotting and reaction of blood on the blood vessels (42,43). The irritation effects and reaction of blood make the blood vessels be in amed.…”

Section: Discussionmentioning

confidence: 99%

Time to Develop Phlebitis and Its Predictors among Patients with Peripheral Intravenous Cannula at Public Hospitals of Bahir Dar City, Amhara, Ethiopia, 2022: A Prospective Follow up Study

Lidetu

Yirga

2022

Preprint

View full text Add to dashboard Cite

Background: Phlebitis is the inflammation of the vein and common complication of peripheral intravenous cannula. Phlebitis leads the patient to sepsis and pulmonary embolism that increase mortality. Literature on Phlebitis is scanty in Ethiopia. Therefore, this study focuses on the time to develop (incidence) and predictors of phlebitis. Methods and Materials: An institution based prospective follow up study was conducted at public Hospitals of Bahir Dar city and 462 patients who were selected through systematic random sampling technique. Phlebitis was identified by Jackson’s Visual Infusion Phlebitis Scoring System. Cox proportional hazards regression model was used. Results: In this study, 462 patients participated, of those, 171(37.01%) acquired phlebitis. The median survival time to develop phlebitis was six days. Age group > 60 years (AHR = 0.49, 95% CI 0.29-0.82) was preventive factor. Whereas, Chronic-diseases (AHR =1.50, 95% CI 1.09-2.07), drugs and blood administer in one vein (AHR=2.03, 95% CI 1.44-2.86), inappropriate cannula dressing (AHR=1.81, 95% CI 1.31-2.51), large cannula size (AHR = 1.52, 95% CI 1.08-2.15) and longer cannula dwelling time (AHR =7.39, 95% CI 4.12-13.32) found as risk factors of phlebitis.Conclusion and recommendation: Younger age, chronic disease, using one intravenous line for more than one purpose, larger cannula size, inappropriate cannula dressing and longer cannula dwelling time were found as risk factors for phlebitis. Therefore, patients with those risk factors need to get special care and follow up.

show abstract

Incidence of Phlebitis Following the Use of Peripheral IV Line at X Hospital

Cited by 4 publications

References 0 publications

Trailblazing exploration: Unraveling phlebitis and its enigmas in children

Trailblazing exploration: Unraveling phlebitis and its enigmas in children

A preliminary study of ecosmart intra venous system on patients’ comfort

Time to Develop Phlebitis and Its Predictors among Patients with Peripheral Intravenous Cannula at Public Hospitals of Bahir Dar City, Amhara, Ethiopia, 2022: A Prospective Follow up Study

Contact Info

Product

Resources

About